Your search returned 11 results.

Results
	1.	Does A1c consistently reflect mean plasma glucose? [electronic resource] by Shrom, David Sarwat, Samiha Ilag, Liza Bloomgarden, Zachary T Producer: 20110202 In: Journal of diabetes vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Detection and prediction of periodic patterns by the retina. [electronic resource] by Schwartz, Greg Harris, Rob Shrom, David Berry, Michael J Producer: 20070712 In: Nature neuroscience vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Assessing the Impact of Improvements in PASI and Itch Scores on Patients' Quality of Life in the Treatment of Psoriasis. [electronic resource] by Yosipovitch, Gil Dong, Yan Burge, Russel Zhu, Baojin Shrom, David Kimball, Alexa B Producer: 20200410 In: Acta dermato-venereologica vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. [electronic resource] by Feng, Ruiben Wang, Huimin Wang, Jianlin Shrom, David Zeng, Xuemei Tsien, Joe Z Producer: 20040709 In: Proceedings of the National Academy of Sciences of the United States of America vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey. [electronic resource] by Merola, Joseph F Shrom, David Eaton, Jennifer Dworkin, Christine Krebsbach, Craig Shah-Manek, Bijal Birt, Julie Publication details: Rheumatology and therapy Mar 2019 In: Rheumatology and therapy vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial. [electronic resource] by Blauvelt, Andrew Lomaga, Mark Burge, Russel Zhu, Baojin Shen, Wei Shrom, David Dossenbach, Martin Pinter, Andreas Producer: 20200407 In: The Journal of dermatological treatment vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis. [electronic resource] by Warren, Richard B Gooderham, Melinda Burge, Russel Zhu, Baojin Amato, David Liu, Karen Huayu Shrom, David Guo, Jiaying Brnabic, Alan Blauvelt, Andrew Producer: 20201124 In: Journal of the American Academy of Dermatology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis. [electronic resource] by Gladman, Dafna D Orbai, Ana-Maria Klitz, Uta Wei, James Cheng-Chung Gallo, Gaia Birt, Julie Rathmann, Suchitrita Shrom, David Marzo-Ortega, Helena Producer: 20200316 In: Arthritis research & therapy vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience. [electronic resource] by Callis Duffin, Kristina Bukhalo, Michael Bobonich, Margaret A Shrom, David Zhao, Fangyi Kershner, James R Gill, Anne Pangallo, Beth Shuler, Catherine L Bagel, Jerry Publication details: Medical devices (Auckland, N.Z.) 2016 In: Medical devices (Auckland, N.Z.) vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood. [electronic resource] by Wang, Claire Q F Suárez-Fariñas, Mayte Nograles, Kristine E Mimoso, Claudia A Shrom, David Dow, Ernst R Heffernan, Michael P Hoffman, Robert W Krueger, James G Producer: 20150218 In: The Journal of investigative dermatology vol. 134 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials. [electronic resource] by Leonardi, Craig Reich, Kristian Foley, Peter Torii, Hideshi Gerdes, Sascha Guenther, Lyn Gooderham, Melinda Ferris, Laura K Griffiths, Christopher E M ElMaraghy, Hany Crane, Heidi Patel, Himanshu Burge, Russel Gallo, Gaia Shrom, David Leung, Ann Lin, Chen-Yen Papp, Kim Publication details: Dermatology and therapy Jun 2020 In: Dermatology and therapy vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)